Import testing turned into an unnecessary limitation of patient access to medicines as risks are managed effectively

Stephan K. Rönninger, Joerg H.O. Garbe
  • Pharmaceuticals Policy and Law, October 2016, IOS Press
  • DOI: 10.3233/ppl-160439
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Joerg Garbe

In partnership with: